Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Other 1

Conditions

Endometrial Neoplasms 2Rectal Neoplasms 1Overweight 1Obesity 1Motor Activity 1Lymphoma, Mantle-Cell 1Lymphoma 1Leukemia 1Infertility 1Genetic Diseases, Inborn 1Breast Neoplasms 1

Interventions

pembrolizumab 14Paclitaxel 14Carboplatin 12Bevacizumab 7Specimen Handling 6Cisplatin 6olaparib 5Taxes 5Fulvestrant 5Nivolumab 4Megestrol Acetate 4Magnetic Resonance Spectroscopy 4Doxorubicin 4Biopsy 4palbociclib 3durvalumab 3Oxaliplatin 3Leucovorin 3Letrozole 3Immunoglobulin G 3Gemcitabine 3Fluorouracil 3Docetaxel 3Disulfides 3trastuzumab deruxtecan 2ribociclib 2pertuzumab 2lenvatinib 2ipatasertib 2dostarlimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Tablets × 30 days × Clear all
NCT05247268 2026-06-04

Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer

Fudan University

Phase 2 Recruiting
104 enrolled
Gynecologic

Endometrial Neoplasms

NCT05316467 2026-06-04

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Fudan University

Phase 2/3 Terminated
8 enrolled
GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡